Clinical trial
Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion
NCT04502017 is registered in ClinicalTrials.gov with Texas Cardiac Arrhythmia Research Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion
- Lead sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 5, 2020
- Completion date
- December 31, 2023
- Enrollment
- 360 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, device-related thrombosis, left atrial appendage occlusion